PRESS RELEASE published on 01/14/2025 at 17:45, 1 year ago ABEO prolonge son partenariat avec la FIBA jusqu'en 2028 - La marque SCHELDE SPORTS équipera, entre autres, la Coupe du Monde de Basket-Ball FIBA 2027 et les épreuves de Basket-Ball des JO de Los Angeles 2028 ABEO annonce le renouvellement de sa marque SCHELDE SPORTS comme fournisseur officiel mondial de la FIBA jusqu'en 2028, renforçant ainsi leur partenariat stratégique dans le basket-ball international Partenariat Basket-ball ABEO FIBA SCHELDE SPORTS
PRESS RELEASE published on 01/14/2025 at 17:45, 1 year ago ABEO and FIBA extend partnership until 2028 - SCHELDE SPORTS brand will supply the FIBA Basketball World Cup 2027 and the Los Angeles 2028 Basketball Olympic Tournaments ABEO announces SCHELDE SPORTS as FIBA Global Supplier for backstop units until 2028. SCHELDE SPORTS continues to play a strategic role in international basketball ABEO FIBA SCHELDE SPORTS Backstop Units International Basketball
PRESS RELEASE published on 01/14/2025 at 17:45, 1 year ago Cibox : Doublement du chiffre d'affaires en 2024 CIBOX, expert français de la micro-mobilité électrique, double son chiffre d'affaires en 2024 avec +104%. Ouverture du site de production définitif à Revin en 2025 Chiffre D'affaires Stratégie Commerciale CIBOX Micro-mobilité Électrique Revin
PRESS RELEASE published on 01/14/2025 at 17:45, 1 year ago Informations privilégiées / Autres communiqués Verimatrix annonce le lancement de DVB ReAccess, une solution CAS over-the-air. L'audit Farncombe Security® de Cartesian a été réussi VERIMATRIX DVB ReAccess CAS Farncombe Security Cartesian
PRESS RELEASE published on 01/14/2025 at 17:44, 1 year ago VALBIOTIS SA: Valbiotis announces the major success of the phase II/III HEART II clinical study on LIPIDRIVE Valbiotis announces success of phase II/III HEART II study on LIPIDRIVE, proving efficacy in reducing LDL cholesterol for mild to moderate hypercholesterolemia. Study validates safety & compliance of Lipidrive Valbiotis Lipidrive Hypercholesterolemia HEART II Study LDL Cholesterol
PRESS RELEASE published on 01/14/2025 at 17:44, 1 year ago VALBIOTIS SA: Valbiotis annonce le large succès de l’étude clinique de phase II/III HEART II sur LIPIDRIVE Valbiotis annonce le large succès de l'étude clinique de phase II/III HEART II sur LIPIDRIVE, démontrant l'efficacité sur la réduction du LDL Cholestérol. L'étude confirme l'approche scientifique innovante de Valbiotis Valbiotis Santé Efficacité Étude Clinique LDL Cholesterol
REGULATED PRESS RELEASE published on 01/14/2025 at 17:40, 1 year ago Infotel : Déclaration des transactions sur actions propres réalisées du 6 au 10 janvier 2025 dans le cadre du programme de rachat d’actions. Communiqué de presse déclarant les transactions sur actions propres d'Infotel du 6 au 10 janvier 2025 dans le cadre du programme de rachat d'actions, consultables sur leur site internet Transactions Sur Actions Propres INFOTEL Programme De Rachat D'actions Euronext B Transformations Digitales
PRESS RELEASE published on 01/14/2025 at 17:20, 1 year ago 5E Advanced Materials Announces Funding Package and Proposed Restructure and Equitization of Convertible Notes 5E Advanced Materials, Inc. announces a $30 million Transaction and RSA with primary lenders to strengthen balance sheet and progress to Final Investment Decision (FID) Transaction Balance Sheet 5E Advanced Materials Funding Package Restructuring Support Agreement
PRESS RELEASE published on 01/14/2025 at 17:03, 1 year ago EQS-Adhoc: Eckert & Ziegler Signs Licence Agreement for Actinium-225 with Chinese Joint Venture Eckert & Ziegler SE signs licence agreement with Chinese joint venture for Ac-225 cyclotron technology, aiming to increase supply of Ac-225 for radiopharmaceutical industry Radiopharmaceutical Industry Eckert & Ziegler SE Licence Agreement Ac-225 Chinese Joint Venture
PRESS RELEASE published on 01/14/2025 at 16:30, 1 year ago Holding(s) in Company Morgan Stanley discloses an increase in voting rights in Britvic plc according to regulatory notification TR-1 on 14-Jan-2025 Voting Rights Britvic Plc TR-1 Notification Shareholding Morgan Stanley
Published on 01/28/2026 at 01:00, 3 hours 7 minutes ago Boron One Announces Increase to Private Placement
Published on 01/27/2026 at 22:15, 5 hours 52 minutes ago Biomind Labs Announces CAD $2.52 Million Private Placement Financing
Published on 01/27/2026 at 20:20, 7 hours 47 minutes ago FutureGen Industries is Unaware of Any Material Change
Published on 01/27/2026 at 19:30, 8 hours 37 minutes ago Taranis Plans Modern Exploration Programs in Brownfield Silver Cup Mining District
Published on 01/27/2026 at 20:19, 7 hours 48 minutes ago Aroundtown SA announces successful €750 million perpetual notes issuance and tender offer launch
Published on 01/27/2026 at 20:17, 7 hours 50 minutes ago Aroundtown SA announces successful €750 million perpetual notes issuance and tender offer launch
Published on 01/27/2026 at 19:16, 8 hours 51 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 01/27/2026 at 18:05, 10 hours 2 minutes ago New indication in children from birth for Guerbet's half-dose GBCA, Elucirem™ (Gadopiclenol) approved by European Commission
Published on 01/27/2026 at 18:00, 10 hours 7 minutes ago GEVELOT S.A.: Weekly declaration of share buybacks – 26/01/2026
Published on 01/27/2026 at 19:00, 9 hours 7 minutes ago MISE A DISPOSITION RAPPORT FINANCIER SEMESTRIEL 2025/2026
Published on 01/27/2026 at 17:45, 10 hours 22 minutes ago Imerys-27-01-2026-information-share-capital-and-voting-rights-as-of-31-December-2025